Aarti Pharmalabs Ltd (AARTIPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003784,
    "name": "Aarti Pharma",
    "stock_name": "Aarti Pharma",
    "full_name": "Aarti Pharmalabs Ltd",
    "name_url": "stocks-analysis/aarti-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "793.25",
    "chg": 21.5,
    "chgp": "2.79%",
    "dir": 1,
    "prev_price": "771.75",
    "mcapval": "7,116.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543748,
    "symbol": "AARTIPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0LRU01027",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.74 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/aarti-pharma-1003784-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Aarti Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-aarti-pharma-technically-bullish-or-bearish-3745746",
        "imagepath": "",
        "date": "2025-12-04 08:51:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 03 Dec 2025, Aarti Pharma's overall technical trend transitioned from bearish to mildly bearish. This subtle change reflects a market environment where downward pressures have somewhat eased, but a clear bullish reversal remains elusive. The mildly bearish classification suggests that while the stock is not in a strong downtrend, it has yet to establish convincing upward momentum.</p>\n<p><strong>Key Technical Indicators Breakdown</strong></p>\n<p>Examining the Moving Average Convergence Divergence (MACD), a widely followed momentum indicator, reveals a bearish stance on the weekly timeframe and a mildly bearish position monthly. This divergence implies that short-term momentum is weaker, and the longer-term trend has not fully recovered.</p>\n..."
      },
      {
        "title": "Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-technical-momentum-shifts-amid-mixed-indicator-signals-3745549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AartiPharmalabs_technicaldot_3745549.png",
        "date": "2025-12-04 08:12:41",
        "description": "Aarti Pharmalabs has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. The pharmaceutical and biotechnology company’s stock price movements and technical signals suggest a period of cautious market assessment as investors digest recent evaluation adjustments."
      },
      {
        "title": "Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-technical-momentum-shifts-amid-mixed-indicator-signals-3743064",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AartiPharmalabs_technicaldot_3743064.png",
        "date": "2025-12-03 08:09:19",
        "description": "Aarti Pharmalabs, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, suggesting evolving investor sentiment and potential implications for the stock’s near-term trajectory."
      },
      {
        "title": "Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-technical-momentum-shifts-amid-mixed-indicator-signals-3740444",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AartiPharmalabs_technicaldot_3740444.png",
        "date": "2025-12-02 08:12:53",
        "description": "Aarti Pharmalabs, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a predominantly bearish outlook to a mildly bearish stance, underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages."
      },
      {
        "title": "How has been the historical performance of Aarti Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-aarti-pharma-3739414",
        "imagepath": "",
        "date": "2025-12-01 23:40:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Since fiscal year ending March 2022, Aarti Pharma’s net sales have shown robust expansion, rising from ₹1,199.94 crores to ₹2,115.07 crores by March 2025. This represents a compound growth rate exceeding 25% annually, reflecting strong market demand and operational scaling. The operating profit margin (excluding other income) has improved from 17.25% in 2022 to 21.95% in 2025, signalling enhanced operational efficiency and cost management.</p>\n<p>Profit after tax (PAT) has also followed an encouraging path, increasing from ₹122.25 crores in 2022 to ₹272.40 crores in 2025. Correspondingly, the PAT margin rose from 10.19% to 12.88%, underscoring the company’s ability to convert sales growth into bottom-line gains. Earnings per share (EPS) have mirrored..."
      },
      {
        "title": "Aarti Pharmalabs: Analytical Revisions Reflect Mixed Signals Amidst Financial and Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3732679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AartiPharmalabs_mojoScore_3732679.png",
        "date": "2025-11-27 08:17:55",
        "description": "Aarti Pharmalabs has undergone a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. The pharmaceutical company’s recent financial disclosures and market behaviour have prompted a nuanced analytical perspective, highlighting both challenges and areas of relative strength amid a complex industry backdrop."
      },
      {
        "title": "Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-technical-momentum-shifts-amid-bearish-signals-3732608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AartiPharmalabs_technicaldot_3732608.png",
        "date": "2025-11-27 08:08:55",
        "description": "Aarti Pharmalabs has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish indicators across multiple timeframes. The stock's recent price action and technical signals suggest a nuanced market assessment, with mixed signals from key momentum and trend-following indicators."
      },
      {
        "title": "Aarti Pharmalabs Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-forms-death-cross-signalling-potential-bearish-trend-3731886",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AartiPharmalabs_dealthcross_3731886.png",
        "date": "2025-11-26 18:01:37",
        "description": "Aarti Pharmalabs, a player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and may indicate weakening momentum in the stock’s price over the longer term."
      },
      {
        "title": "Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-technical-momentum-shifts-amid-mixed-indicator-signals-3717121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AartiPharmalabs_technicaldot_3717121.png",
        "date": "2025-11-20 08:09:10",
        "description": "Aarti Pharmalabs, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish stance, with technical indicators presenting a nuanced picture for investors and market watchers alike."
      }
    ],
    "total": 251,
    "sid": "1003784",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/aarti-pharmalabs-1003784"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for 1. Board Meeting Intimation For Unaudited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2025 2. Declaration Of Interim Dividend If Any On The Equity Share Capital Of The Company For The Fi",
      "datetime": "29-Jan-2026",
      "details": "Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. Unaudited Financial Results of the Company for the quarter and nine-months ended December 31 2025 after these results are reviewed by the Audit Committee of the Board. 2. Declaration of Interim Dividend if any on the equity share capital of the Company for the Financial Year 2025-26.",
      "source": "BSE"
    },
    {
      "caption": "Clarification With Respect To Increase In Volume",
      "datetime": "12-Jan-2026",
      "details": "Please find attached clarifciation with respect to increase in volume",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Aarti Pharmalabs Ltd",
      "datetime": "12-Jan-2026",
      "details": "The Exchange has sought clarification from Aarti Pharmalabs Ltd on January 12 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Pharmalabs Ltd has declared <strong>50%</strong> dividend, ex-date: 15 Sep 25",
          "dt": "2025-09-15",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Aarti Pharma technically bullish or bearish?

2025-12-04 08:51:19

Recent Technical Trend Shift As of 03 Dec 2025, Aarti Pharma's overall technical trend transitioned from bearish to mildly bearish. This subtle change reflects a market environment where downward pressures have somewhat eased, but a clear bullish reversal remains elusive. The mildly bearish classification suggests that while the stock is not in a strong downtrend, it has yet to establish convincing upward momentum. Key Technical Indicators Breakdown Examining the Moving Average Convergence Divergence (MACD), a widely followed momentum indicator, reveals a bearish stance on the weekly timeframe and a mildly bearish position monthly. This divergence implies that short-term momentum is weaker, and the longer-term trend has not fully recovered. ...

Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals

2025-12-04 08:12:41

Aarti Pharmalabs has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. The pharmaceutical and biotechnology company’s stock price movements and technical signals suggest a period of cautious market assessment as investors digest recent evaluation adjustments.

Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:09:19

Aarti Pharmalabs, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, suggesting evolving investor sentiment and potential implications for the stock’s near-term trajectory.

Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:12:53

Aarti Pharmalabs, a key player in the Pharmaceuticals & Biotechnology sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition from a predominantly bearish outlook to a mildly bearish stance, underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages.

How has been the historical performance of Aarti Pharma?

2025-12-01 23:40:54

Revenue and Profit Growth Since fiscal year ending March 2022, Aarti Pharma’s net sales have shown robust expansion, rising from ₹1,199.94 crores to ₹2,115.07 crores by March 2025. This represents a compound growth rate exceeding 25% annually, reflecting strong market demand and operational scaling. The operating profit margin (excluding other income) has improved from 17.25% in 2022 to 21.95% in 2025, signalling enhanced operational efficiency and cost management. Profit after tax (PAT) has also followed an encouraging path, increasing from ₹122.25 crores in 2022 to ₹272.40 crores in 2025. Correspondingly, the PAT margin rose from 10.19% to 12.88%, underscoring the company’s ability to convert sales growth into bottom-line gains. Earnings per share (EPS) have mirrored...

Aarti Pharmalabs: Analytical Revisions Reflect Mixed Signals Amidst Financial and Technical Shifts

2025-11-27 08:17:55

Aarti Pharmalabs has undergone a revision in its market assessment following a detailed evaluation of its quality, valuation, financial trends, and technical indicators. The pharmaceutical company’s recent financial disclosures and market behaviour have prompted a nuanced analytical perspective, highlighting both challenges and areas of relative strength amid a complex industry backdrop.

Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals

2025-11-27 08:08:55

Aarti Pharmalabs has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish indicators across multiple timeframes. The stock's recent price action and technical signals suggest a nuanced market assessment, with mixed signals from key momentum and trend-following indicators.

Aarti Pharmalabs Forms Death Cross Signalling Potential Bearish Trend

2025-11-26 18:01:37

Aarti Pharmalabs, a player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and may indicate weakening momentum in the stock’s price over the longer term.

Aarti Pharmalabs Technical Momentum Shifts Amid Mixed Market Signals

2025-11-20 08:09:10

Aarti Pharmalabs, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments highlight a transition from a sideways trend to a mildly bearish stance, with technical indicators presenting a nuanced picture for investors and market watchers alike.

View All News